Xenon Pharmaceuticals Stock Forecast

Stock Price Forecast

The 11 analysts that cover Xenon Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $53.91, which forecasts a 22.80% increase in the stock price over the next year. The lowest target is $43 and the highest is $67.

Price Target: $53.91 (+22.80%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$43	$53.91	$55	$67
Change	-2.05%	+22.80%	+25.28%	+52.62%

Analyst Ratings

The average analyst rating for Xenon Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	5	5	5	5	5	5
Buy	6	5	6	6	6	6
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	10	11	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Benjamin Burnett Wells Fargo	Wells Fargo	Buy Maintains $44 → $48	Buy	Maintains	$44 → $48	+9.34%	Dec 11, 2025
Tessa Romero JP Morgan	JP Morgan	Buy Maintains $57 → $60	Buy	Maintains	$57 → $60	+36.67%	Nov 18, 2025
Brian Abrahams RBC Capital	RBC Capital	Buy Maintains $55 → $58	Buy	Maintains	$55 → $58	+32.12%	Nov 4, 2025
Benjamin Burnett Wells Fargo	Wells Fargo	Buy Maintains $48 → $44	Buy	Maintains	$48 → $44	+0.23%	Nov 4, 2025
Serge Belanger Needham	Needham	Strong Buy Reiterates $55	Strong Buy	Reiterates	$55	+25.28%	Nov 4, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

7.68M

Revenue Next Year

5.10M

from 7.68M

-33.61%

from 7.68M

EPS This Year

-4.33

from -3.01

EPS Next Year

-4.81

from -4.33

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	32.17M	18.44M	9.43M	-	-	7.68M	5.10M
Revenue Growth	371.02%	-42.68%	-48.83%	-	-	-	-33.61%
EPS	-0.80	-1.77	-2.06	-2.73	-3.01	-4.33	-4.81
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	22	22

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	8.4M	26.3M
Avg	7.7M	5.1M
Low	7.4M	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	241.7%
Avg	-	-33.6%
Low	-	-

EPS Forecast

EPS	2025	2026
High	-4.24	-4.15
Avg	-4.33	-4.81
Low	-4.46	-5.63

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.